Michael F. Berger

Michael F. Berger is an Assistant Professor at Weill Cornell Medicine's Graduate School of Medical Sciences and Co-Director of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology at Memorial Sloan Kettering Cancer Center (MSKCC). He serves as the inaugural Chief of the Clinical Computational Diagnostics Service in the Department of Pathology and Laboratory Medicine at MSKCC.

• Education: PhD in Biophysics from Harvard University; Bachelor’s in Physics from Princeton University

Research Interests: Berger specializes in genomic and computational techniques to identify molecular drivers of cancer and develop targeted therapies. His work focuses on biomarker discovery, tumor evolution, and clinical implementation of next-generation sequencing assays like MSK-IMPACT (FDA-authorized tumor profiling) and MSK-ACCESS (liquid biopsy).

Recent Articles: His publications highlight population-scale clinical genomic datasets, integrating mutational signatures, clonality, and ancestry in cancer progression. Key trends include applications of machine learning, liquid biopsies, and genome-derived tumor typing for personalized medicine.

Grants & Collaborations: Berger collaborates with clinical leaders at MSKCC, leveraging large-scale sequencing data for translational research. His lab explores inherited variants, clonal hematopoiesis, and drug resistance mechanisms through clinical partnerships.

Labs & Teams: He leads the Michael Berger Lab at MSKCC, part of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology and the Gerstner Sloan Kettering Graduate School of Biomedical Sciences.